An ongoing immune response to HIV envelope gp120 in human CD4-transgenic mice contributes to T cell decline upon intravenous administration of gp120

European Journal of Immunology

Volumn 28, Issue 8, 1998, Pages 2253-2264

  Kang, Yubin ^a   Melo, E F Marco ^a   Scott, David W ^a  

^a HOLLAND LABORATORY   (United States)

Author keywords

Apoptosis; gp120; Human CD4 transgenic mouse; Humoral immune response; T cell deletion

Indexed keywords

CD4 ANTIGEN; GLYCOPROTEIN GP 120; LIPOCORTIN 5;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; BOLUS INJECTION; CONTROLLED STUDY; CROSS REACTION; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTE COUNT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; SPLEEN CELL; STAINING; T LYMPHOCYTE; TRANSGENIC MOUSE; VIRUS ENVELOPE;

ANIMALS; ANTIGENS, CD3; ANTIGENS, CD4; APOPTOSIS; B-LYMPHOCYTES; CD4 LYMPHOCYTE COUNT; FEMALE; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HUMANS; IMMUNIZATION; INJECTIONS, INTRAVENOUS; LYMPHOID TISSUE; LYMPHOPENIA; MALE; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; MURAMIDASE; RECOMBINANT PROTEINS; T-LYMPHOCYTES;

EID: 0031928666     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199808)28:08<2253::AID-IMMU2253>3.0.CO;2-2     Document Type: Article

References (48)

1. Ameisen, J. C. and Capron, A., Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis. Immunol. Today 1991. 12: 102-105.
2. Starcich, B. R., Hahn, B. H., Shaw, G. M., McNeely, P. D., Modrow, S., Wolf, H., Parks, E. S., Parks, W. P., Josephs, S. F., Gallo, R. C. and Wong-Staal, F., Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS. Cell 1986. 45: 637-648.
3. Abacioglu, Y. H., Fouts, T. R., Laman, J. D., Claassen, E., Pincus, S. H., Moore, J. P., Roby, C. A., Kamin-Lewis, R. and Lewis, G. K., Epitope mapping and topology of baculovirus expressed HIV-1 gp120 determined with a panel of murine monoclonal antibodies. AIDS Res. Hum. Retroviruses 1994. 10: 371-381.
4. Bour, S., Geleziunas, R. and Wainberg, M. A., The role of CD4 and its downmodulation in establishment and maintenance of HIV-1 infection. Immunol. Rev. 1994. 140: 147-171.
5. Willey, R. L., Rutledge, R. A., Dias, S., Folks, T., Theodore, T., Buckler, C. E. and Martin, M. A., Identification of conserved and divergent domains within the envelope gene of the acquired immunodeficiency syndrome retrovirus. Proc. Natl. Acad. Sci. USA 1986. 83: 5038-5042.
6. Weiss, R. A., Clapham, P. R., Cheingsong-Popov, R., Dalgleish, A. G., Carne, C. A., Weller, I. V. D. and Tedder, R. S., Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients. Nature 1985. 316: 69-72.
7. Katz, D. H., AIDS: primarily a virus or an autoimmune disease. AIDS Res. Hum. Retroviruses 1993. 9: 489-493.
8. Golding, H., Robey, F. A., Gates, F. T., Linder, W., Beining, P. R., Hoffman, J. and Golding, B., Identification of homologous regions in human immunodeficiency virus I gp41 and human MHC class II beta 1 domain. I, monoclonal antigens against the gp41-derived peptide and patients' sera react with native HLA class II antigens, suggesting a role for autoimmunity in the pathogenesis of acquired immune deficiency syndrome. J. Exp. Med. 1988. 167: 914-923.
9. Kion, T. A. and Hoffman, G. W., Anti-HIV and anti-MIC antibodies in alloimmune and autoimmune mice. Science 1991. 253: 1138-1140.
10. + T cells. Proc. Natl. Acad. Sci. USA 1996. 93: 11014-11018.
11. Banda, N. K., Bernier, J., Kurahara, D. K., Kurrle, R., Haigwood, N., Sekaly, R.-P. and Finkel, T. H., Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J. Exp. Med. 1992. 176: 1099-1106.
12. Newell, M. K., Haughn, L. J., Maroun, C. R. and Julius, M. H., Death of mature T cells by separate ligation of CD4 and the T cell receptor for antigen. Nature 1990. 347: 286-289.
13. Oyaizu, N., McCloskey, T. W., Than, S., Hu, R., Kalyanaraman, V. S. and Pahwa, S., Cross-linking of CD4 molecules upregulates Fas antigen expression in lymphocytes by inducing interferon-γ and tumor necrosis factor-α secretion. Blood 1994. 84: 2622-2631.
14. Wang, Z., Dudhane, A., Orlikowsky, T., Clarke, K., Li, X., Darzynkiewicz, Z. and Hoffmann, M. K., CD4 engagement induces Fas antigen-dependent apoptosis of T cells in vivo. Eur. J. Immunol. 1994. 24: 1549-1552.
15. Wang, Z., Orlikowsky, T., Dudhane, A., Mittler, R., Blum, M., Lacy, E., Riethmüller, G. and Hoffmann, M. K., Deletion of T lymphocytes in human CD4 transgenic mice induced by HIV-gp120 and gp120 specific antibodies from AIDS patients. Eur. J. Immunol. 1994. 24: 1553-1557.
16. + T-cell depletion in mice doubly transgenic for HIV gp120 and human CD4. Eur. J. Immunol. 1997. 27: 1319-1324.
17. Zagury, J. F., Cantalloube, H., Achour, A., Cho, Y. Y., Fall, L., Lachgar, A., Chams, V., Astgen, A., Biou, D., Picard, O., Callebaut, I., Mornon, J. P., Burny, A., Feldman, M., Bernard, J., Bizzini, B. and Zagury, D., Striking similarities between HIV-1 Env protein and the apoptosis mediating cell surface antigen Fas. Role in the pathogenesis of AIDS. Biomed. Pharmacother. 1993. 47: 331-335.
18. Silvestris, F., Nagata, S., Cafforio, P., Silvestris, N. and Dammacco, F., Cross-linking of Fas by antibodies to a peculiar domain of gp120 V3 loop can enhance T-cell apoptosis in HIV-1-infected patients. J. Exp. Med. 1996. 184: 2287-2300.
19. Moukrim, Z. and Achour, A., Cytotoxic T lymphocytes specific for the synthetic VEINCTR peptide, a sequence found within the Fas molecule and env gp120 in the blood of HIV-1 seropositive individuals. Cell. Mol. Biol. 1995. 41: 439-444.
20. Goronzy, J., Weyand, C. M. and Fathman, C. G., Long-term humoral unresponsiveness in vivo, induced by treatment with monoclonal antibody against L3T4. J. Exp. Med. 1986. 164: 911-925.
21. Jamali, I., Field, E. H., Fleming, A. and Cowdery, J. S., Kinetics of anti-CD4-induced T helper cell depletion and inhibition of function: activation of T cells by the CD3 pathway inhibits anti-CD4-mediated T-cell elimination and down-regulation of cell surface CD4. J. Immunol. 1992. 148: 1613-1619.
22. Muro-Cacho, C. A., Pantaleo, G. and Fauci, A. S., Analysis of apoptosis in lymph nodes of HIV-infected persons: Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden. J. Immunol. 1995. 154: 5555-5566.
23. Chun, T.-W., Carruth, L., Finzi, D., Shen, X., DiGiuseppe, J. A., Taylor, H., Hermankova, M., Chadwick, K., Margolick, J., Quinn, T. C., Kuo, Y.-H., Brookmeyer, R., Zeiger, M. A., Barditch-Crovo, P. and Siliciano, R. F., Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 1997. 387: 183-188.
24. Harper, M. E., Marselle, L. M., Gallo, R. C. and Wong-Staal, F., Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization. Proc. Natl. Acad. Sci. USA 1986. 83: 772-776.
25. Lorès, P., Boucher, V., Mackay, C., Pla, M., Boehmer, H., Jami, J., Barrésinoussi, F. and Weill, J.-C., Expression of human CD4 in transgenic mice does not confer sensitivity to human immunodeficiency virus infection. AIDS Res. Hum. Retroviruses 1992. 8: 2063-2071.
26. Feng, Y., Broder, C. C., Kennedy, P. E. and Berger, E. A., HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996. 272: 872-877.
27. Vermes, I., Haanen, C., Steffens-Nakken, H. and Reutelingsperger, C., A novel assay for apoptosis: flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Methods 1995. 184: 39-51.
28. Paterson, R. K., Burkly, L. C., Kurahara, D. K., Dunlap, A., Flavell, R. A. and Finkel, T. H., Thymic development in human CD4 transgenic mice: positive selection occurs after commitment to the CD8 lineage. J. Immunol. 1994. 153: 3491-3503.
29. Klatzmann, D., Champagne, E., Chamaret, S., Gruest, J., Guetard, D., Hercend, T., Gluckman, J.-C. and Montagnier, L., T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 1984. 312: 767-768.
30. Hoxie, J. A., Alpers, J. D., Rackowski, J. L., Huebner, K., Haggarty, B. S., Cedarbaum, A. J. and Reed, J. C., Alterations in T4 (CD4) protein and mRNA synthesis in cells infected with HIV. Science 1986. 234: 1123-1127.
31. Scott, D. W., Grdina, T. and Shi, Y., T cells commit suicide, but B cells are murdered. J. Immunol. 1996. 156: 2352-2356.
32. Lanzavecchia, A., How can cryptic epitopes trigger autoimmunity. J. Exp. Med. 1995. 181: 1945-1948.
33. Salemi, S., Caporossi, A. P., Boffa, L., Longobardi, M. G. and Barnaba, V., HIVgp120 activates autoreactive CD4-specific T cell response by unveiling of hidden CD4 peptide during processing. J. Exp. Med. 1995. 181: 2253-2257.
34. + cell depletion. Cell 1988. 54: 561-575.
35. + antigen-specific T cells to undergo apoptosis by HIV-infected monocytes: a two-step mechanism involving the gp120 molecule. J. Clin. Invest. 1996. 99: 257-266.
36. Macatonia, S. E., Lau, R., Patterson, S., Pinching, A. J. and Knight, S. C., Dendritic cell infection, depletion and dysfunction in HIV-infected individuals. Immunology 1990. 71: 38-45.
37. Zambidis, E. T., Kurup, A. and Scott, D. W., Genetically transferred central and peripheral immune tolerance via retroviral-mediated expression of immunogenic epitopes in hematopoietic progenitors or peripheral B lymphocytes. Mol. Med. 1997. 3: 212-224.
38. Posner, M. R., Cavacini, L. A., Emes, C. L., Power, J. and Byrn, R., Neutralization of HIV-1 by F105, a human monoclonal antibody to the CD4 binding site of gp120. J. Acquir. Immune Defic. Syndr. 1993. 6: 7-14.
39. Cavacini, L. A., Emes, C. L., Power, J., Buchbinder, A., Zolla-Pazner, S. and Posner, M. R., Human monoclonal antibodies to the V3 loop of HIV-1 gp120 mediate variable and distinct effects on binding and viral neutralization by a human monoclonal antibody to the CD4 binding site. J. Acquir. Immune Defic. Syndr. 1993. 6: 353-358.
40. Posner, M. R., Elboim, H. and Santos, D., The construction and use of a human-mouse myeloma analogue suitable for the routine production of hybridomas secreting human monoclonal antibodies. Hybridoma 1987. 6: 611-625.
41. Posner, M. R., Hideshima, T., Cannon, T., Mukherjee, M., Mayer, K. H. and Byrn, R. A., An IgG monoclonal antibody that reacts with HIV-1/gp120, inhibits virus binding to cells, and neutralizes infection. J. Immunol. 1991. 146: 4325-4332.
42. Ugen, K. E., Refaeli, Y., Ziegner, U., Agadjanyan, M., Satre, M. A. R., Srikantan, V., Wang, B., Sato, A., Williams, W. V. and Weiner, D., Generation of monoclonal antibodies against the amino terminus of gp120 that elicit antibody dependent cellular cytotoxity. In: Ginsberg, H. S., Brown, F. and Lerner, R. A. (Eds.) Vaccines 93, Cold Spring Harbor Laboratory Press, Cold Spring Harbor 1993, pp 215-221.
43. Haigwood, N. L., Schuster, J. R., Moore, G. K., Lee, H., Skiles, P. V., Higgins, K. H., Barr, P. J., George-Nascimento, C. and Steimer, K. S., Importance of hypervariable regions of HIV-1 gp120 in the generation of virus neutralizing antibodies. AIDS Res. Hum. Retroviruses 1990. 6: 855-869.
44. Steimer, K. S., Van Nest, G. A., Haigwood, N. L., Tillson, E. M., George-Nascimento, C., Barr, P. J. and Dina, D., Recombinant env and gag polypeptides in characterizing HIV-1 neutralizing antibodies. In: Ginsberg, H. S., Brown, F., Lerner, R. A. and Chanock, R. M. (Eds.) Vaccines 88, Cold Spring Harbor Laboratory Press, Cold Spring Harbor 1988, pp 347-355.
45. Levy, J. A., Hoffman, A. D., Kramer, S. M., Landis, J. A., Shimabukuro, J. M. and Oshiro, L. S., Isolation of lymphocytopathic retrovirus from San Francisco patients with AIDS. Science 1984. 225: 840-842.
46. Sanchez-Pescador, R., Power, M. D., Barr, P. J., Steimer, K. S., Stempien, M. M., Brown-Shimer, S. L., Gee, W. W., Renard, A., Randolph, A., Levy, J. A., Dina, D. and Luciw, P. A., Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-I). Science 1985. 227: 484-492.
47. Haigwood, N. L., Barker, C. B., Higgins, K. H., Skiles, P. V., Moore, G. K., Mann, K. A., Lee, D. R., Eichberg, J. W. and Steimer, K. S., Evidence for neutralizing antibodies directed against confirmational epitopes of HIV-1 gp120. In: Brown, F., Chanock, R. M., Ginsberg, H. S. and Lerner, R. A. (Eds.) Vaccines 90, Cold Spring Harbor Laboratory Press, Cold Spring Harbor 1990, pp 313-320.
48. 1 growth arrest of murine B cell lymphomas. Mol. Biol. Cell 1996. 7: 553-564.